Companies/US/KLRS

KALARIS THERAPEUTICS, INC.

Last · NASDAQ$2.18+0.05 (+2.35%)live · yahoo · 3h ago
Vol 30.8K ≈ 67.2K
Market cap$51.89M23.8M sh
P/E · TTM-1.1fwd -1.3 · eps -1.95 · loss
Beta—vs S&P 500
Div yield0.00%annual · TTM
52w range
$2.10$11.88
Volume30.8Ksession

Issuer

Legal nameKALARIS THERAPEUTICS, INC.
HQUnited States (US)
ListingUS KLRS
ISINUS4829291065
SectorHealthcare
IndustryBiotechnology & Medical Research
SIC2836
CurrencyUSD
Entity registrysec:0001754068
CIK0001754068
Websiteinvestors.kalaristx.com
Employees20
Loading chart…

Press & signals

2 recent
  • GlobeNewswire

    Kalaris Reports Second Quarter 2026 Financial Results and Provides Business Updates

  • GlobeNewswire

    Kalaris Expands Leadership Team Appointing Liisa Bayko as Chief Financial Officer

Documents

FormReporting forFiledFlags
4
2026-08-272026-08-280
8-K8-K: Results of Operations and Financial Condition
2026-08-112026-08-110
10-Q
2026-06-302026-08-11 3
4
2026-08-012026-08-030
8-K8-K: Departure of Directors or Certain Officers; Election of Directors
2026-07-032026-07-060
Showing 5 of 11 filings